| Crystalloid group (n = 66) | Colloid group (n = 130) | Control group (n = 130) | p |
---|---|---|---|---|
Anesthesia time (min) | 188 (145–250) | 197 (170–254) | 185 (160–230) | 0.168a |
Surgery time (min) | 119 (84–162) | 135 (107–171) | 125 (99–159) | 0.063a |
Cumulative amount of infused volume (ml) | 2575 (2000–4210) | 2435 (1760–3480) | 2210 (1658–3000) | 0.063a |
Crystalloids (ml) | 2250 (1750–3000) | 725 (500–1000) | 1500 (1000–2000) |  < 0.001a |
Colloids (ml) | 0 (0–0) | 1250 (1000–1750) | 500 (500–1000) |  < 0.001a |
Median SV (ml) | 65 (54–74) | 67.5 (60–75.25) | - | 0.96c |
Inotropes (%) | 19 (28.8%) | 28 (21.5%) | 18 (13.8%) |  < 0.001b |
Blood transfusion (%) | 18 (27.3%) | 57 (43.8%) | 47 (36.2%) | 0.071b |
Intraoperative blood loss (ml) | 800 (475–1200) | 1000 (500–1500) | 800 (485–1500) | 0.562a |
Necessity NE | 25 (37.9%) | 20 (25.4%) | 31 (40.3%) | 0.002 |
Average max. NE-dose (µg/kg Bodyweight/min) | 0.027 | 0.0133 | 0.0191 | 0.004a |
NE at end of surgery | 10 (15.2%) | 10 (7.7%) | 18 (13.8%) | 0.185b |
Postoperative admission to | 0.223b | |||
 Recovery room | 45 (68.2%) | 71 (54.6%) | 75 (57.7%) | |
 PACU | 18 (27.3%) | 53 (40.8%) | 44 (33.8%) | |
 ICU | 3 (4.5%) | 6 (4.6%) | 11 (8.5%) | |
LOS | ||||
 Recovery room (min) | 150 (115.5–190) | 160 (110–205) | 170 (120–240) | 0.177a |
 PACU/ICU (min) | 750 (427.5–1235) | 400 (207–825) | 960 (360–1210) |  < 0.001a |